{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-018972","form_type":"8-K","ticker":"RVPH","cik":"0001742927","company_name":"REVIVA PHARMACEUTICALS HOLDINGS, INC.","filed_at":"2025-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.535198+00:00","generated_at":"2026-05-20T04:34:22.916414+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Reviva Pharmaceuticals enters into ATM sales agreement for up to $50M common stock offering","bullets":["On May 30, 2025, Reviva entered an ATM agreement with B. Riley Securities and Alliance Global Partners to sell up to $50M of common stock.","Sales will be made through Nasdaq as an 'at the market offering' under Rule 415; agents receive 3% commission.","Shares issued under effective shelf registration statement (Form S-3 filed Feb 2024).","No obligation for agents to sell any specific amount; they use commercially reasonable efforts based on company instructions."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-018972","json":"https://secwatch.observer/filing/0001437749-25-018972.json","markdown":"https://secwatch.observer/filing/0001437749-25-018972.md","text":"https://secwatch.observer/filing/0001437749-25-018972.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1742927/000143774925018972/0001437749-25-018972-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1742927/000143774925018972/rvph20250513_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T04:34:22.916414+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}